BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu J, Fu M, Wang M, Wan D, Wei Y, Wei X. Cancer vaccines as promising immuno-therapeutics: platforms and current progress. J Hematol Oncol 2022;15:28. [PMID: 35303904 DOI: 10.1186/s13045-022-01247-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Liao Z, Huang J, Lo PC, Lovell JF, Jin H, Yang K. Self-adjuvanting cancer nanovaccines. J Nanobiotechnology 2022;20:345. [PMID: 35883176 DOI: 10.1186/s12951-022-01545-z] [Reference Citation Analysis]
2 Jiang C, Li J, Zhang W, Zhuang Z, Liu G, Hong W, Li B, Zhang X, Chao C. Potential association factors for developing effective peptide-based cancer vaccines. Front Immunol 2022;13:931612. [DOI: 10.3389/fimmu.2022.931612] [Reference Citation Analysis]
3 Sadeghi Najafabadi SA, Bolhassani A, Aghasadeghi MR. Tumor cell-based vaccine: an effective strategy for eradication of cancer cells. Immunotherapy 2022;14:639-54. [PMID: 35481358 DOI: 10.2217/imt-2022-0036] [Reference Citation Analysis]
4 Yang M, Olaoba OT, Zhang C, Kimchi ET, Staveley-o’carroll KF, Li G. Cancer Immunotherapy and Delivery System: An Update. Pharmaceutics 2022;14:1630. [DOI: 10.3390/pharmaceutics14081630] [Reference Citation Analysis]
5 Gupta SL, Basu S, Soni V, Jaiswal RK. Immunotherapy: an alternative promising therapeutic approach against cancers. Mol Biol Rep 2022. [PMID: 35759082 DOI: 10.1007/s11033-022-07525-8] [Reference Citation Analysis]
6 To N, Evans RPT, Pearce H, Kamarajah SK, Moss P, Griffiths EA. Current and Future Immunotherapy-Based Treatments for Oesophageal Cancers. Cancers 2022;14:3104. [DOI: 10.3390/cancers14133104] [Reference Citation Analysis]